| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Angela Cox | Q28484012 |
| P2093 | author name string | Ping Yang | |
| Jie Dai | |||
| Gening Jiang | |||
| P2860 | cites work | Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study | Q84292391 |
| Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors | Q84615356 | ||
| Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling | Q84750798 | ||
| Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice | Q84768328 | ||
| Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy | Q84874900 | ||
| The Effects of a Multidisciplinary Care Conference on the Quality and Cost of Care for Lung Cancer Patients | Q85905898 | ||
| Similar radiopathological features, but different postoperative recurrence rates, between Stage I lung cancers arising in emphysematous lungs and those arising in nonemphysematous lungs | Q87578247 | ||
| Diagnosing COPD and targeted lung cancer screening | Q95421918 | ||
| Preoperative smoking habits and postoperative pulmonary complications. | Q51525407 | ||
| Surgical risk evaluation of lung cancer in COPD patients - A cohort observational study. | Q51525474 | ||
| Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease. | Q51602168 | ||
| Assessment of volume reduction effect after lung lobectomy for cancer. | Q51638756 | ||
| Quality of life after tailored combined surgery for stage I non-small-cell lung cancer and severe emphysema. | Q51639510 | ||
| The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. | Q51711303 | ||
| Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. | Q51886413 | ||
| Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. | Q51898509 | ||
| Pulmonary emphysema and tumor microenvironment in primary lung cancer. | Q52912749 | ||
| Estimating overdiagnosis of lung cancer. | Q53113021 | ||
| Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. | Q53718509 | ||
| COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours. | Q55069669 | ||
| Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer: The Importance of Smoking and Timing of Diagnosis | Q61843533 | ||
| Effect of Smoking Reduction on Lung Cancer Risk | Q61875233 | ||
| Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery | Q74509009 | ||
| Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer | Q79842448 | ||
| A clinical practice guideline update on the diagnosis and management of stable chronic obstructive pulmonary disease | Q83167018 | ||
| Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 | ||
| Statins and the risk of lung cancer: a meta-analysis | Q21559688 | ||
| Benefits and harms of CT screening for lung cancer: a systematic review | Q24600624 | ||
| Impact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studies | Q26777142 | ||
| The stats are in: an update on statin use in COPD | Q26778906 | ||
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 | ||
| Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis | Q27336183 | ||
| Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD. | Q27339178 | ||
| The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD | Q27349146 | ||
| Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review | Q28069762 | ||
| Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer | Q28388778 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 | ||
| Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study | Q33509281 | ||
| Overdiagnosis in low-dose computed tomography screening for lung cancer | Q33691938 | ||
| Improving selection criteria for lung cancer screening. The potential role of emphysema. | Q33735712 | ||
| An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer | Q33738504 | ||
| Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO) | Q34021037 | ||
| Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis | Q34205329 | ||
| Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study | Q34315274 | ||
| Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors | Q34355113 | ||
| The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial | Q34394365 | ||
| Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement | Q34394907 | ||
| Is previous respiratory disease a risk factor for lung cancer? | Q34425781 | ||
| Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysis | Q34430876 | ||
| Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment | Q34476776 | ||
| The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease | Q34546085 | ||
| COPD prevalence is increased in lung cancer, independent of age, sex and smoking history | Q34604212 | ||
| CT screening for lung cancer: Importance of emphysema for never smokers and smokers | Q50439150 | ||
| Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis. | Q50771309 | ||
| Lobectomy improves ventilatory function in selected patients with severe COPD. | Q50862893 | ||
| Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database. | Q51136624 | ||
| Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer. | Q51460309 | ||
| Factors associated with undiagnosed and overdiagnosed COPD. | Q51502560 | ||
| Issues with implementing a high-quality lung cancer screening program | Q38224354 | ||
| Clinical practice. Lung-cancer screening with low-dose computed tomography | Q38265211 | ||
| Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis | Q38542022 | ||
| Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway | Q38795202 | ||
| COPD, emphysema and the onset of lung cancer. A systematic review. | Q38964121 | ||
| Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. | Q39955550 | ||
| History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis | Q40204149 | ||
| Lung Cancer Screening in Individuals with Chronic Obstructive Pulmonary Disease. Finding the Sweet Spot. | Q40375169 | ||
| Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease | Q40832326 | ||
| Determinants of underdiagnosis of COPD in national and international surveys. | Q40965998 | ||
| Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis | Q41009788 | ||
| Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO. | Q41172165 | ||
| Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling | Q41199112 | ||
| The relationship between perioperative administration of inhaled corticosteroid and postoperative respiratory complications after pulmonary resection for non-small-cell lung cancer in patients with chronic obstructive pulmonary disease | Q41290076 | ||
| Measures of outcome in lung cancer screening: maximising the benefits. | Q42369335 | ||
| Lung cancer histologies associated with emphysema on computed tomography | Q43779895 | ||
| Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis | Q44293317 | ||
| Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer | Q44392191 | ||
| Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease | Q44491538 | ||
| Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study | Q44782927 | ||
| Estimating overdiagnosis of lung cancer--reply. | Q45070417 | ||
| High-intensity training and cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease and non-small-cell lung cancer undergoing lobectomy | Q45854550 | ||
| Impact of lobectomy for non-small-cell lung cancer on respiratory function in octogenarian patients with mild to moderate chronic obstructive pulmonary disease☆ | Q46725566 | ||
| Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines | Q48178931 | ||
| Does chronic obstructive pulmonary disease affect postoperative quality of life in patients undergoing lobectomy for lung cancer? A case-matched study | Q48974958 | ||
| Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. | Q34679354 | ||
| Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials | Q35035835 | ||
| Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. | Q35153428 | ||
| Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease | Q35193704 | ||
| Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis | Q35537826 | ||
| Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease | Q35565178 | ||
| Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study | Q35598608 | ||
| Trends in the proportion of patients with lung cancer meeting screening criteria | Q35825640 | ||
| Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations | Q35837368 | ||
| Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease | Q35855187 | ||
| Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer | Q35967703 | ||
| COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study | Q35988214 | ||
| Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD). | Q36145536 | ||
| Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy | Q36272396 | ||
| Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality | Q36490128 | ||
| Impact of GOLD groups of chronic pulmonary obstructive disease on surgical complications | Q36585742 | ||
| Mortality in COPD: Role of comorbidities. | Q36670236 | ||
| Interobserver variability in the determination of upper lobe-predominant emphysema | Q36734384 | ||
| Association of radiographic emphysema and airflow obstruction with lung cancer | Q36915507 | ||
| Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study | Q37125913 | ||
| Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease | Q37186804 | ||
| Chronic obstructive lung diseases and risk of non-small cell lung cancer in women | Q37350689 | ||
| ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). | Q37536535 | ||
| The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection | Q37553312 | ||
| Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence | Q37562594 | ||
| Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients | Q37579720 | ||
| Preoperative pulmonary rehabilitation in patients with non-small cell lung cancer and chronic obstructive pulmonary disease | Q37636820 | ||
| Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study. | Q37644907 | ||
| Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. | Q37699490 | ||
| Pharmacological actions of statins: potential utility in COPD | Q37801150 | ||
| Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes | Q37823042 | ||
| Is preoperative physiotherapy/pulmonary rehabilitation beneficial in lung resection patients? | Q37876564 | ||
| Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review | Q37884743 | ||
| Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection | Q38005654 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
| lung cancer | Q47912 | ||
| pulmonary hernia | Q4273065 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 18513-18524 | |
| P577 | publication date | 2017-01-04 | |
| 2017-03-14 | |||
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective | |
| P478 | volume | 8 |
| Q90216029 | Antineoplastic therapy side effects and polypharmacy in older adults with cancer |
| Q56561137 | CT Radiomics in Thoracic Oncology: Technique and Clinical Applications |
| Q91756348 | Differential expression and functional analysis of lung cancer gene expression datasets: A systems biology perspective |
| Q47093979 | Gendermetrics of cancer research: results from a global analysis on lung cancer |
| Q59792625 | Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity |
| Q99582945 | Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms |
| Q55003550 | The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case-control study. |
| Q51764891 | Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease. |
Search more.